Status | Study |
Recruiting |
Study Name: Italian Network MDS Registry Condition: Myelodysplastic-Myeloproliferative Diseases Date: 2016-05-18 |
Recruiting |
Study Name: A Phase 1 Study Evaluating CPI-0610 in Patients With Acute Leukemia, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasms, and Myelofibrosis Condition: Leukemia, Myelocytic, Acute Myelodysplastic Syndrome (MDS) Date: 2014-06-05 Interventions: Drug: CPI-0610 |
Active, not recruiting |
Study Name: Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Condition: Leukemia Myelodysplastic Syndromes M Date: 2007-01-19 Interventions: Biological: sargramostim Drug: bexarotene |
Completed |
Study Name: Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders Condition: Chronic Myeloproliferative Disorders Leukemia Date: 2006-02-16 Interventions: Drug: clofarabine Drug: cyclophosphamide |
Completed |
Study Name: Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes Condition: Leukemia Myelodysplastic Syndromes M Date: 2005-09-20 Interventions: Biological: anti-thymocyte globulin Biolog |
Terminated |
Study Name: Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes Condition: Leukemia Myelodysplastic Syndromes M Date: 2005-03-03 Interventions: Dietary Supplement: cholecalciferol |
Completed |
Study Name: Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes Condition: Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Date: 2004-12-07 Interventions: Drug: amifostine trihydrate |
Completed |
Study Name: Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes Condition: Leukemia Myelodysplastic Syndromes M Date: 2004-10-06 Interventions: Biological: etanercept Drug: arsenic triox |
Completed |
Study Name: 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome Condition: Leukemia Myelodysplastic Syndromes M Date: 2004-02-10 Interventions: Drug: fludarabine phosphate Drug: triapine |
Completed |
Study Name: Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Condition: Leukemia Myeloproliferative Disorders Date: 2004-01-09 Interventions: Biological: Allogeneic bone marrow transplantation |